CV Sciences

Las Vegas, United States Founded: 2010 • Age: 16 yrs
Cannabidiol-based pharmaceuticals and consumer products are developed and distributed.
Annual revenue $15.7M Latest available
Total funding $55,050 7 rounds
Employees 49 Tracked headcount
Investors - Known backers
Products 5 Services tracked
Competitors 10 Brand Intelligence

About CV Sciences

CV Sciences is a company based in Las Vegas (United States) founded in 2010 by Michael Mona. CV Sciences has raised $55.05 thousand across 7 funding rounds. The company has 49 employees as of December 31, 2024. CV Sciences has completed 3 acquisitions, including Cultured Foods, Elevated Softgels and Extract Labs. CV Sciences offers products and services including PlusCBD Oil, Balm, Edibles, Skincare, and Softgels. CV Sciences operates in a competitive market with competitors including Lucid Green, Curio Wellness, Wana Brands, Parallel and Cannawayz, among others.

  • Headquarter Las Vegas, United States
  • Employees 49 as on 31 Dec, 2024
  • Founders Michael Mona
  • Stage Public
  • Sectors
    Consumer
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Cv Sciences, Inc.
Operational Areas
Consumer → Tobacco, Cannabis & Alternative Products Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $15.71 M (USD)
    -1.87
    as on Dec 31, 2024
  • Net Profit
    -$2.39 M (USD)
    -177.18
    as on Dec 31, 2024
  • EBITDA
    -$1.86 M (USD)
    16.58
    as on Dec 31, 2024
  • Total Equity Funding
    $55.05 K (USD)

    in 7 rounds

  • Latest Funding Round
    $750 K (USD), Post-IPO

    Mar 31, 2017

  • Investors
    Not available
  • Employee Count
    49

    as on Dec 31, 2024

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of CV Sciences

CV Sciences is a publicly listed company on the OTC with ticker symbol CVSI in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: OTC · Ticker: CVSI · Sector: Health technology · USA

Products & Services of CV Sciences

CV Sciences offers a comprehensive portfolio of products and services, including PlusCBD Oil, Balm, Edibles, Skincare, and Softgels.

Product name locked
Category locked
Primary

CBD oil product for supporting overall wellness and health benefits.

Product name locked
Category locked
Locked

Topical balm with CBD for targeted pain and skin relief.

Product name locked
Category locked
Locked

CBD-infused edibles for daily wellness consumption.

Product name locked
Category locked
Locked

CBD-based skincare items for skin health maintenance.

Product name locked
Category locked
Locked

CBD softgels for convenient daily health supplementation.

People of CV Sciences

Headcount 10-50
Employee Profiles 14
Employee Profiles
People
Daniel Degner
FP&A Manager
People
Aleksandar Sakota
Inside Sales Manager
People
Tom Ball
National Sales Manager
People
Nicholas Gaeta
Lead Account Executive

Unlock access to complete

Funding Insights of CV Sciences

CV Sciences has successfully raised a total of $55.05K across 7 strategic funding rounds. The most recent funding activity was a Post-IPO round of $750 thousand completed in March 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by CV Sciences

CV Sciences has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Cultured Foods, Elevated Softgels and Extract Labs.

Investments
Premium access

Investment portfolio details for CV Sciences

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Private label cannabis research and production services are offered.
Locked Locked 2019 Locked
Provider of all-natural, vegan, and gluten-free products with probiotics
Locked Locked 2017 Locked
CBD-infused products are manufactured and supplied by Extract Labs.
Locked Locked 2016 Locked
Premium access

Complete acquisition details for CV Sciences

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - CV Sciences

Premium access

Detailed financials for CV Sciences

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Cv Sciences Comparisons

CV Sciences Primary company
Description
Cannabidiol-based pharmaceuticals and consumer products are ...
Location
Las Vegas, United States
Founded Year
2010
Annual Revenue
$15.71 M (USD)
Net Profit
-$2.39 M (USD)
EBITDA
-$1.86 M (USD)
Employees
49
As of 2024
Premium access

Peer comparison for CV Sciences

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of CV Sciences

CV Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lucid Green, Curio Wellness, Wana Brands, Parallel and Cannawayz, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Cannabis-based product information is provided for consumer education.
Locked Locked Locked
Medical cannabis products for sleep disorders are provided.
Locked Locked Locked
Cannabis-infused jellies in various flavors are developed for consumers.
Locked Locked Locked
Parallel is engaged in AI-native product design and user experience solutions.
Locked Locked Locked
Online platform connecting users to cannabis dispensaries, products, and exclusive offers.
Premium access

Detailed competitors of CV Sciences

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Cv Sciences

Premium access

Complete news archive for CV Sciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about CV Sciences

CV Sciences was founded in 2010.

CV Sciences is headquartered in Las Vegas, United States. It is registered at Las Vegas, Nevada, United States.

Joseph Dowling is the current CEO of CV Sciences.

CV Sciences is a funded company, having raised a total of $55.05K across 7 funding rounds to date.

As of Dec 31, 2024, the latest employee count at CV Sciences is 49.

Annual revenue of CV Sciences is $15.71M as on Dec 31, 2024.

CV Sciences was founded in 2010 and is headquartered in Las Vegas, United States. Operations focus on the development of cannabidiol-based pharmaceuticals and consumer products within the health and wellness sector. A hemp-derived CBD oil has been produced and made available through online channels, health food stores, and practitioners offices. Leadership includes co-founder Michael Mona and CEO Joseph Dowling.

CV Sciences's top competitors include Curio Wellness, Lucid Green and Wana Brands.

CV Sciences offers PlusCBD Oil, Balm, Edibles, Skincare, and Softgels.

Yes, CV Sciences is publicly traded on OTC under the ticker symbol CVSI.

CV Sciences has made 3 acquisitions, including Cultured Foods, Elevated Softgels, and Extract Labs.

The ticker symbol of CV Sciences is CVSI on OTC.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available